Form 10-K · Annual report
Visa Inc. 10-K, filed Nov 5, 2026
- Filed
- CIK
- 0001403161
- Accession no.
- 0001403161-26-000134
Summary
Visa Inc. reported fiscal 2026 net revenue of $45.9 billion, up 15% from the prior year, with net income of $23.5 billion and diluted earnings per share of $12.32, and said it agreed in August 2026 to acquire fraud-intelligence provider BioCatch for $2.4 billion in cash, subject to regulatory approvals.
Key points
- Visa acquired Prisma Medios de Pago and Newpay in Argentina for $1.5 billion in cash in February 2026.
- Visa recorded $1.6 billion in additional accruals for the interchange multidistrict litigation during fiscal 2026 and deposited $1.3 billion more into the U.S. litigation escrow account.
- Visa's board authorized an additional $20.0 billion share repurchase program in April 2026, and the company repurchased 61 million class A shares for $20.5 billion during fiscal 2026.
- Visa processed 281.3 billion transactions in fiscal 2026, up 9% year over year.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
ITEM 7. Management’s Discussion Overview Visa is a global payments technology company that facilitates secure, reliable and efficient global commerce and money movement. We provide transaction processing services (primarily authorization, clearing and settlement) among consumers, issuing and acquiring financial institutions and sellers. We are focused on extending, enhancing and investing in our proprietary advanced transaction processing network, VisaNet, to offer a single connection point for facilitating money movement to multiple endpoints through various form factors and innovative technologies across more than 200 countries and territories. Visa is not a financial institution. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.